Standard care plan for Prophylactic Cranial Irradiation for Limited Stage (stage I-III) Small Cell Lung Cancer (25Gy in 10 fractions) References
|
|
- Jeremy Bailey
- 5 years ago
- Views:
Transcription
1 CHEMOTHERAPY CARE PLAN Document Title: Document Type: Subject: Approved by: Prophylactic Cranial Irradiation for Limited-stage Small Cell Lung Cancer (20Gy in 5 fractions) Clinical Guideline Standard Care Plan Currency: Review date: Author(s): Standard care plan for Prophylactic Cranial Irradiation for Limited Stage (stage I-III) Small Cell Lung Cancer (25Gy in 10 fractions) References Auperin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999; 341: Le Pechoux C, Dunant A, Senan S, et al. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC , RTOG 0212, and IFCT 99-01): a randomised clinical trial. Lancet Oncol 2009; 10: A randomized study evaluating the optimal PCI dose in limited disease Komaki R, Meyers CA, Shin DM, et al. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys 33 (1): , 1995 database. Patient group Limited-Stage (stage I-III) Small Cell Lung Cancer After any response to chemotherapy Filename 1.LS SCLC_PCI_Care plan Last modified 27-Mar-15 Last printed 27-Mar-15 Page 1 of 6 Agreed by (on behalf of the team) Neil Bayman
2 Indications Any response to chemotherapy confirmed on CT scan. No clinical/radiological evidence of brain metastases on CT or MRI Performance score (PS) of 0, 1 or 2 Contraindications No response to chemotherapy Epilepsy (suitability for PCI to be discussed on a case by case basis) Established cerebro-vascular disease (suitability for PCI to be discussed on a case by case basis) PS 3 or 4 Evidence A meta-analysis of 7 RCTs evaluating the role of PCI in patients in complete remission after chemotherapy reported improvement in brain recurrence, disease free survival and overall survival with the addition of PCI (Auperin). Prospective studies have shown that patients treated with PCI do not have significantly worse neuropsychological function than patients not treated (Auperin, Komaki). The EULINT PCI trial is a multicentre randomised controlled trial comparing high dose (36 Gy in 18 fractions) to standard dose (25 Gy in 10 fractions) radiotherapy to the whole brain. The primary end point is the reduction in the incidence of brain metastases at 2 years. The trial recruited 720 patients. Patients who received a higher PCI dose (36 Gy) had a nonsignificant decrease in brain metastases as compared with patients who received the standard dose; the brain metastases 2-year rate was 29%in the standard dose group and 23% in the high-dose group [hazard ratio 0.80, 95% confidence interval (CI) , P 0.18]. For unclear reasons, OS was worse among patients in the higher dose PCI group (hazard ratio for death 1.2, 95% CI ) (Le Pechoux). Outcome Patients whose cancer can be controlled have a 60% actuarial risk of developing brain metastasis within 2 to 3 years after staring treatment. This risk can be decreased by 50% by the administration of PCI. Page 2 of 6 27/03/2015
3 Auperin NEJM,1999 Toxicity Lethargy, hair loss, scalp reaction, headaches, nausea 1. Initial investigations and work up prior to start of treatment 1.1. Initial diagnostic review and work up as per Limited Stage Small Cell guidelines Post chemotherapy CT scan to assess disease response. CT or MR brain if symptoms suggestive of brain metastases are present. 2. Radiotherapy Technique for PCI 2.1. Patient treatment position and set-up Simulated and treated supine with lateral parallel opposed fields. Immobilised in a thermoplastic shell Set up should be by reference to marks placed on the shell at simulation Patient data acquisition Page 3 of 6 27/03/2015
4 2.3. Target volume delineation Field definition: inferior bony landmarks of the base of the skull (Riedel s Baseline) and superior, anterior and posterior 1cm beyond the bony skull. Field projection is checked to ensure eyes/lens are spared and adjusted accordingly Organs at risk (delineation and dose constraints) 2.5. Dose prescription The dose will be specified at mid-plane, 25 Gy in 10 daily fractions 2.6. Verification: 2.7. Treatment Delays: 3. On treatment assessments 3.1. Clinical assessment by medical team including Graded documentation of toxicity Assessment of disease related symptoms Performance status recorded 3.2. Management of treatment related toxicity Skin Reaction Topical treatment with emollient (E45 or aqueous cream) and 1% Hydrocortisone cream as required Nausea and vomiting Oral anti emetics Consider oral steroids for prophylaxis/treatment of symptoms Headache Simple analgesia increased as necessary Consider oral steroids for prophylaxis/treatment of symptoms Post treatment follow-up Further follow-up with referring medical oncologist. Page 4 of 6 27/03/2015
5 Page 5 of 6 27/03/2015
6 Appendices ECOG PERFORMANCE STATUS* Grade ECOG 0 Fully active, able to carry on all pre-disease performance without restriction 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work 2 Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours 3 Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours 4 Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair 5 Dead Page 6 of 6 27/03/2015
Role of Prophylactic Cranial Irradiation in Small Cell Lung Cancer
Role of Prophylactic Cranial Irradiation in Small Cell Lung Cancer Kazi S. Manir MD,DNB,ECMO,PDCR Clinical Tutor Department of Radiotherapy R. G. Kar Medical College and Hospital, Kolkata SCLC 15% of lung
More informationProphylactic Cranial Irradiation and Thoracic Radiotherapy in Extensive Stage Small-Cell Lung Cancer
Prophylactic Cranial Irradiation and Thoracic Radiotherapy in Extensive Stage Small-Cell Lung Cancer Dr Neil Bayman Consultant Clinical Oncology ESMO-Christie Preceptorship Programme in Lung Cancer, March
More informationCécile Le Péchoux Department of Radiation Oncology, Institut Gustave Roussy, Villejuif France Amsterdam 2010
Prophylactic Cranial Irradiation in Lung Cancer Cécile Le Péchoux Department of Radiation Oncology, Institut Gustave Roussy, Villejuif France Amsterdam 2010 Prophylactic cranial irradiation PCI was introduced
More informationProtocol of Radiotherapy for Small Cell Lung Cancer
107 年 12 月修訂 Protocol of Radiotherapy for Small Cell Lung Cancer Indication of radiotherapy Limited stage: AJCC (8th edition) stage I-III (T any, N any, M0) that can be safely treated with definitive RT
More informationThe Role of Radiotherapy in the Treatment of Small-Cell Lung Cancer
Curr. Treat. Options in Oncol. (2015) 16: 56 DOI 10.1007/s11864-015-0372-2 Lung Cancer (HA Wakelee, Section Editor) The Role of Radiotherapy in the Treatment of Small-Cell Lung Cancer Kaname Nosaki, M.D.
More informationUpdate on Limited Small Cell Lung Cancer. Laurie E Gaspar MD, MBA Prof/Chair Radiation Oncology University of Colorado Denver
Update on Limited Small Cell Lung Cancer Laurie E Gaspar MD, MBA Prof/Chair Radiation Oncology University of Colorado Denver Objectives - Limited Radiation Dose Radiation Timing Radiation Volume PCI Neurotoxicity
More informationStandard care plan for 1 st line palliative chemotherapy in advanced non small cell lung cancer References
CHEMOTHERAPY CARE PLAN Document Title: Document Type: Subject: Approved by: Currency: Carboplatin & Gemcitabine combination chemotherapy (Lung cancer) Clinical Guideline Standard Care Plan 2 Years Review
More informationBrain metastases are detected in approximately 20%
COUNTERPOINTS Current Controversies in Hematology and Oncology Should All Patients With SCLC Receive Prophylactic Cranial Irradiation If They Have Responded to Treatment? Brain metastases are common in
More informationES-SCLC Joint Case Conference. Anthony Paravati Adam Yock
ES-SCLC Joint Case Conference Anthony Paravati Adam Yock Case 57 yo woman with 35 pack year smoking history presented with persistent cough and rash Chest x-ray showed a large left upper lobe/left hilar
More informationProphylactic cranial irradiation or no prophylactic cranial irradiation in metastatic small cell lung cancer: is it a relevant question once again?
Editorial Prophylactic cranial irradiation or no prophylactic cranial irradiation in metastatic small cell lung cancer: is it a relevant question once again? Cecile Le Pechoux 1, Angela Botticella 1, Antonin
More informationNon-uniform dose distributions in whole brain radiotherapy
Non-uniform dose distributions in whole brain radiotherapy Edward T. Bender April 23, 2010 Under the supervision of: Dr. Wolfgang Tomé Outline Background Information Whole brain radiotherapy and small
More informationRadiotherapy Protocols
Radiotherapy Protocols Cranial Irradiation for Palliative Whole Brain for Metastases and Prophylactic Whole Brain for SCLC Prepared by: Dr C Blesing, Dr N Warner, Dr D Cutter, Ms R Watson, Ms L Drummond,
More informationPlace de la radiothérapie dans les CBPC métastatiques
Place de la radiothérapie dans les CBPC métastatiques Cecile Le Péchoux, 12 ème Biennale Monégasque de Cancérologie, 2016 IOT Institut d Oncologie Thoracique CBPC metastatique Rapid doubling time, early
More informationStandard care plan for stereotactic body radiotherapy for non-small-cell lung cancer
RADIOTHERAPY PROTOCOL Document Title: Document Type: Subject: Approved by: Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer (54-60 Gy in 3-8 fractions) Clinical Guideline Standard Care Plan
More informationOriginal Date: April 2016 Page 1 of 7 FOR CMS (MEDICARE) MEMBERS ONLY
National Imaging Associates, Inc. Clinical guidelines STEREOTACTIC RADIATION THERAPY: STEREO RADIOSURGERY (SRS) AND STEREOTACTIC BODY RADIATION THERAPY (SBRT) CPT4 Codes: Please refer to pages 5-6 LCD
More informationProphylactic cranial irradiation for extensive-stage small-cell lung cancer: an evolving view
Editorial Prophylactic cranial irradiation for extensive-stage small-cell lung cancer: an evolving view Ethan B. Ludmir, Steven H. Lin Department of Radiation Oncology, The University of Texas MD Anderson
More informationAdjuvant Radiotherapy for completely resected NSCLC
Adjuvant Radiotherapy for completely resected NSCLC ESMO Preceptorship on lung Cancer Manchester February 2017 Cécile Le Péchoux Radiation Oncology Department IOT Institut d Oncologie Thoracique Local
More informationTreatment outcomes of patients with small cell lung cancer without prophylactic cranial irradiation
Original Article Treatment outcomes of patients with small cell lung cancer without prophylactic cranial irradiation Masakuni Sakaguchi 1, Toshiya Maebayashi 1, Takuya Aizawa 1, Naoya Ishibashi 1, Tsutomu
More information1 Oregon Health & Science University, Portland, OR 2 Stritch School of Medicine, Loyola University Chicago, Chicago, IL
Current treatment practices for limited-stage small cell lung cancer: A survey of US radiation oncologists on the timing of thoracic radiotherapy with chemotherapy Matthew J. Farrell 1, Jehan Yahya 1,
More informationConcomitant (without adjuvant) temozolomide and radiation to treat glioblastoma: A retrospective study
Concomitant (without adjuvant) temozolomide and radiation to treat glioblastoma: A retrospective study T Sridhar 1, A Gore 1, I Boiangiu 1, D Machin 2, R P Symonds 3 1. Department of Oncology, Leicester
More informationMinesh Mehta, Northwestern University. Chicago, IL
* Minesh Mehta, Northwestern University Chicago, IL Consultant: Adnexus, Bayer, Merck, Tomotherapy Stock Options: Colby, Pharmacyclics, Procertus, Stemina, Tomotherapy Board of Directors: Pharmacyclics
More informationStandard care plan for Carboplatin and Etoposide Chemotherapy References
CHEMOTHERAPY CARE PLAN Document Title: Document Type: Subject: Approved by: Currency: Carboplatin/Etoposide Chemotherapy Clinical Guideline Standard Care Plan 2 Years Review date: Author(s): Standard care
More informationDistribution of brain metastases: implications for non-uniform dose prescriptions
The British Journal of Radiology, 84 (2011), 649 658 Distribution of brain metastases: implications for non-uniform dose prescriptions 1 E T BENDER, PhD and 1,2 W A TOMÉ, PhD, FAAPM 1 Department of Human
More informationOptimal Management of Isolated HER2+ve Brain Metastases
Optimal Management of Isolated HER2+ve Brain Metastases Eliot Sims November 2013 Background Her2+ve patients 15% of all breast cancer Even with adjuvant trastuzumab 10-15% relapse Trastuzumab does not
More informationPulmonary function tests 3. Is patient potentially operable? Yes. Inoperable. Yes. Zubrod performance status
te: Consider Clinical Trials as treatment options for eligible patients. INITIAL EVALUATION Pathology consistent with SCLC History and physical Chest x-ray Laboratory studies to include hematological and
More informationGUIDELINES FOR RADIOTHERAPY IN SPINAL CORD COMPRESSION THE CHRISTIE, GREATER MANCHESTER & CHESHIRE. Version:
GUIDELINES FOR RADIOTHERAPY IN SPINAL CORD COMPRESSION THE CHRISTIE, GREATER MANCHESTER & CHESHIRE Procedure Reference: Document Owner: Dr V. Misra Version: Accountable Committee: V4 Acute Oncology Group
More informationSan Antonio Breast Cancer Symposium 2010 Highlights Radiotherapy
San Antonio Breast Cancer Symposium 2010 Highlights Radiotherapy Kathleen C. Horst, M.D. Assistant Professor Department of Radiation Oncology Stanford University The Optimal SEquencing of Adjuvant Chemotherapy
More informationSmall Cell Lung Cancer (SCLC)
te: Consider Clinical Trials as treatment options for eligible patients. INITIAL EVALUATION Small Cell Lung Cancer (SCLC) Page 1 of 8 STAGE FURTHER ASSESSMENT Pathology consistent with SCLC History and
More informationRadiation Therapy in SCLC. What is New? Prof. Dr. Hoda Abdel Baky El Bakry Cairo Cancer Institute Radiation Oncology Department
Radiation Therapy in SCLC What is New? Prof. Dr. Hoda Abdel Baky El Bakry Cairo Cancer Institute Radiation Oncology Department Background Overview Small Cell Lung cancer constitute about 15 % of all newly
More informationDebate 1 Are treatments for small cell lung cancer getting better? No:
Debate 1 Are treatments for small cell lung cancer getting better? No: Taofeek Owonikoko, MD, PhD Associate Professor Department of Hematology & Medical Oncology Winship Cancer Institute of Emory University
More informationThe Role of Radiation Therapy in the Treatment of Brain Metastases. Matthew Cavey, M.D.
The Role of Radiation Therapy in the Treatment of Brain Metastases Matthew Cavey, M.D. Objectives Provide information about the prospective trials that are driving the treatment of patients with brain
More informationRadiotherapy in NSCLC: State-of-the-art
Radiotherapy in NSCLC: State-of-the-art Prof. Dirk De Ruysscher, MD, PhD Radiation Oncologist Maastro clinic, Maastricht University Medical Center, GROW Maastricht The Netherlands Disclosure Advisory board
More informationCombining chemotherapy and radiotherapy of the chest
How to combine chemotherapy, targeted agents and radiotherapy in locally advanced NSCLC? Dirk De Ruysscher, MD, PhD Radiation Oncologist Professor of Radiation Oncology Leuven Cancer Institute Department
More informationPalliative treatments for lung cancer: What can the oncologist do?
Palliative treatments for lung cancer: What can the oncologist do? Neil Bayman Consultant Clinical Oncologist GM Cancer Palliative Care and Lung Cancer Education Event Manchester, 31 st January 2017 Most
More informationEvaluation of Whole-Field and Split-Field Intensity Modulation Radiation Therapy (IMRT) Techniques in Head and Neck Cancer
1 Charles Poole April Case Study April 30, 2012 Evaluation of Whole-Field and Split-Field Intensity Modulation Radiation Therapy (IMRT) Techniques in Head and Neck Cancer Abstract: Introduction: This study
More informationProphylactic cranial irradiation in small cell lung cancer: A single-center experience.
Biomedical Research 2017; 28 (16): 7122-7126 ISSN 0970-938X www.biomedres.info Prophylactic cranial irradiation in small cell lung cancer: A single-center experience. Öztun Temelli 1*, Nihal Kaplan Bozdag
More informationIntroduction: Methods: Results: Conclusions: PATIENTS AND METHODS Key Words: 1770
Original Article Utilization of Hyperfractionated Radiation in Small-Cell Lung Cancer and Its Impact on Survival David Schreiber, MD,* Andrew T. Wong, MD,* David Schwartz, MD,* and Justin Rineer, MD Introduction:
More informationCancer Treatment in the Elderly. Jeffrey A. Bubis, DO, FACOI, FACP Clay County, Baptist South, and Palatka
Cancer Treatment in the Elderly Jeffrey A. Bubis, DO, FACOI, FACP Clay County, Baptist South, and Palatka Patients 65 and older are the fastest growing segment of the US population By 2030, it will comprise
More informationMetastasi cerebrali La Radioterapia: tecnica, frazionamento, radiosensibilizzanti
Metastasi cerebrali La Radioterapia: tecnica, frazionamento, radiosensibilizzanti Brain Metastases Radiation Therapy of multiple brain metastases Is treatment appropriate? - Survival - QoL Brain Metastases
More informationRadiotherapy for Rectal Cancer. Kevin Palumbo Adelaide Radiotherapy Centre
Radiotherapy for Rectal Cancer Kevin Palumbo Adelaide Radiotherapy Centre Overview CRC are common (3 rd commonest cancer) rectal Ca approx 25-30% of all CRC. Presentation PR bleeding: beware attributing
More informationThe New England Journal of Medicine PROPHYLACTIC CRANIAL IRRADIATION FOR PATIENTS WITH SMALL-CELL LUNG CANCER IN COMPLETE REMISSION
PROPHYLACTIC CRANIAL IRRADIATION FOR PATIENTS WITH SMALL-CELL LUNG CANCER IN COMPLETE REMISSION ANNE AUPÉRIN, M.D., RODRIGO ARRIAGADA, M.D., JEAN-PIERRE PIGNON, M.D., PH.D., CÉCILE LE PÉCHOUX, M.D., ANNA
More informationRadiotherapy Physics and Equipment
Radiological Sciences Department Radiotherapy Physics and Equipment RAD 481 Lecture s Title: Introduction Dr. Mohammed EMAM Ph.D., Paris-Sud 11 University Vision :IMC aspires to be a leader in applied
More informationThis LCD recognizes these two distinct treatment approaches and is specific to treatment delivery:
National Imaging Associates, Inc. Clinical guidelines STEREOTACTIC RADIOSURGERY (SRS) AND STEREOTACTIC BODY RADIATION THERAPY (SBRT) CPT4 Codes: 77371, 77372, 77373 LCD ID Number: L33410 J-N FL Responsible
More informationAdjuvant radiotherapy for completely resected early stage NSCLC
Adjuvant radiotherapy for completely resected early stage NSCLC ESMO Preceptorship on lung Cancer Manchester March 2018 Cécile Le Péchoux Radiation Oncology Department IOT Institut d Oncologie Thoracique
More informationEvaluation of Monaco treatment planning system for hypofractionated stereotactic volumetric arc radiotherapy of multiple brain metastases
Evaluation of Monaco treatment planning system for hypofractionated stereotactic volumetric arc radiotherapy of multiple brain metastases CASE STUDY Institution: Odette Cancer Centre Location: Sunnybrook
More informationReirradiazione. La radioterapia stereotassica ablativa: torace. Pierluigi Bonomo Firenze
Reirradiazione La radioterapia stereotassica ablativa: torace Pierluigi Bonomo Firenze Background Stage III NSCLC isolated locoregional recurrence in 25% of pts mostly unresectable; low RR with 2 nd line
More informationTHERAPY OF SMALL-CELL LUNG CANCER Peter Berzinec Specialised Hospital of St Zoerardus Zobor Teaching Base of the Slovak Medical University Nitra,
THERAPY OF SMALL-CELL LUNG CANCER Peter Berzinec Specialised Hospital of St Zoerardus Zobor Teaching Base of the Slovak Medical University Nitra, Slovakia Lancet. 1966;2(7471):979-86. First standard treatment:
More informationTratamiento Multidisciplinar de Estadios Localmente Avanzados en Cáncer de Pulmón
Tratamiento Multidisciplinar de Estadios Localmente Avanzados en Cáncer de Pulmón Santiago Ponce Aix Servicio Oncología Médica Hospital Universitario 12 de Octubre Madrid Stage III: heterogenous disease
More informationRESEARCH ARTICLE. Evrim Bayman 1 *, Durmus Etiz 1, Melek Akcay 1, Guntulu Ak 2. Abstract. Introduction
DOI:http://dx.doi.org/10.7314/APJCP.2014.15.15.6263 RESEARCH ARTICLE Timing of Thoracic Radiotherapy in Limited Stage Small Cell Lung Cancer: Results of Early Versus Late Irradiation from a Single Institution
More informationA Comparison of IMRT and VMAT Technique for the Treatment of Rectal Cancer
A Comparison of IMRT and VMAT Technique for the Treatment of Rectal Cancer Tony Kin Ming Lam Radiation Planner Dr Patricia Lindsay, Radiation Physicist Dr John Kim, Radiation Oncologist Dr Kim Ann Ung,
More informationClinical Commissioning Policy: Stereotactic Body Radiotherapy / Stereotactic Ablative Radiotherapy. December Reference : NHSCB/B1a
Clinical Commissioning Policy: Stereotactic Body Radiotherapy / Stereotactic Ablative Radiotherapy December 2012 Reference : NHSCB/B1a NHS Commissioning Board Clinical Commissioning Policy: Stereotactic
More informationOriginal Study. 40 Clinical Lung Cancer January 2013
Original Study Prophylactic Cranial Irradiation for Patients With Limited-Stage Small-Cell Lung Cancer With Response to Chemoradiation Patricia Tai, 1 Avi Assouline, 2 Kurian Joseph, 3 Larry Stitt, 4 Edward
More informationCLINICAL MEDICAL POLICY
Policy Name: Policy Number: Approved By: Provider Notice Date: CLINICAL MEDICAL POLICY Portrazza (Necitumumab) MP-021-MD-WV Medical Management Original Effective Date: 06/02/2016 Annual Approval Date:
More informationStrategies of Radiotherapy for Intermediate- to High-Risk Prostate Cancer
Strategies of Radiotherapy for Intermediate- to High-Risk Prostate Cancer Daisaku Hirano, MD Department of Urology Higashi- matsuyama Municipal Hospital, Higashi- matsuyama- city, Saitama- prefecture,
More informationNew Technologies for the Radiotherapy of Prostate Cancer
Prostate Cancer Meyer JL (ed): IMRT, IGRT, SBRT Advances in the Treatment Planning and Delivery of Radiotherapy. Front Radiat Ther Oncol. Basel, Karger, 27, vol. 4, pp 315 337 New Technologies for the
More informationRyoko Suzuki 1, Xiong Wei 1, Pamela K. Allen 1, James W. Welsh 1, James D. Cox 1, Ritsuko Komaki 1 and Steven H. Lin 1,2*
Suzuki et al. Radiation Oncology (2018) 13:258 https://doi.org/10.1186/s13014-018-1205-9 RESEARCH Open Access Outcomes of re-irradiation for brain recurrence after prophylactic or therapeutic whole-brain
More informationMetastatic Spinal Cord Compression
Metastatic Spinal Cord Compression Dr Zacharias Tasigiannopoulos Clinical Oncologist Colney centre Department of Oncology Norwich, UK Introduction 2-5% of cancer patients have an episode of MSCC Initial
More informationScottish Medicines Consortium
Scottish Medicines Consortium temozolomide 5, 20, 100 and 250mg capsules (Temodal ) Schering Plough UK Ltd No. (244/06) New indication: for the treatment of newly diagnosed glioblastoma multiforme concomitantly
More informationCALGB Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer
CALGB 30610 Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer Jeffrey A. Bogart Department of Radiation Oncology Upstate Medical University Syracuse, NY Small Cell Lung Cancer Estimated 33,000
More informationNorthern Suburbs Clinic for Lung Cancer (NSCLC): Targeting Lung Cancer
Northern Suburbs Clinic for Lung Cancer (NSCLC): Targeting Lung Cancer Page 1 Phuong Tran (Rad Onc) Lung Cancer Most common cause of cancer related deaths in Australia 19% of all cancer deaths Survival
More informationThe Physics of Oesophageal Cancer Radiotherapy
The Physics of Oesophageal Cancer Radiotherapy Dr. Philip Wai Radiotherapy Physics Royal Marsden Hospital 1 Contents Brief clinical introduction Imaging and Target definition Dose prescription & patient
More informationOncological Management of Brain Tumours. Anna Maria Shiarli SpR in Clinical Oncology 15 th July 2013
Oncological Management of Brain Tumours Anna Maria Shiarli SpR in Clinical Oncology 15 th July 2013 Outline General considerations of Primary Brain Tumours: epidemiology, pathology, presentation. Diagnosis
More informationStereotactic Radiosurgery. Extracranial Stereotactic Radiosurgery. Linear accelerators. Basic technique. Indications of SRS
Stereotactic Radiosurgery Extracranial Stereotactic Radiosurgery Annette Quinn, MSN, RN Program Manager, University of Pittsburgh Medical Center Using stereotactic techniques, give a lethal dose of ionizing
More informationBenefits of postoperative thoracic radiotherapy for small cell lung cancer subdivided by lymph node stage: a systematic review and meta-analysis
Original Article Benefits of postoperative thoracic radiotherapy for small cell lung cancer subdivided by lymph node stage: a systematic review and meta-analysis Shuling Zhang, Xin Sun, Li Sun, Zhicheng
More informationSMALL CELL LUNG CANCER Updated Feb 2017 by Dr. Doreen Ezeife (PGY-5 Medical Oncology Resident, University of Calgary)
SMALL CELL LUNG CANCER Updated Feb 2017 by Dr. Doreen Ezeife (PGY-5 Medical Oncology Resident, University of Calgary) Reviewed by Dr. Desiree Hao (Staff Medical Oncologist, University of Calgary) and Dr.
More informationAdjuvant Chemotherapy
State-of-the-art: standard of care for resectable NSCLC Adjuvant Chemotherapy JY DOUILLARD MD PhD Professor of Medical Oncology Integrated Centers of Oncology R Gauducheau University of Nantes France Adjuvant
More informationSmall-cell lung cancer (SCLC) is an aggressive neuroendocrine
ORIGINAL ARTICLE Tolerability of Accelerated Chest Irradiation and Impact on Survival of Prophylactic Cranial Irradiation in Patients with Limited-stage Small Cell Lung Cancer: Review of a Single Institution
More informationCombined modality treatment for N2 disease
Combined modality treatment for N2 disease Dr Clara Chan Consultant in Clinical Oncology 3 rd March 2017 Overview Background The evidence base Systemic treatment Radiotherapy Future directions/clinical
More informationChapter 5 Stage III and IVa disease
Page 55 Chapter 5 Stage III and IVa disease Overview Concurrent chemoradiotherapy (CCRT) is recommended for stage III and IVa disease. Recommended regimen for the chemotherapy portion generally include
More informationRole of Belly Board Device in the Age of Intensity Modulated Radiotherapy for Pelvic Irradiation
Role of Belly Board Device in the Age of Intensity Modulated Radiotherapy for Pelvic Irradiation 2017 AAMD 42 nd Annual Meeting Neil C. Estabrook, MD 6 / 14 / 2017 7/5/2017 1 Conflicts of Interest None
More informationAdvances in Breast Surgery. Catherine Campo, D.O. Breast Surgeon Meridian Health System April 17, 2015
Advances in Breast Surgery Catherine Campo, D.O. Breast Surgeon Meridian Health System April 17, 2015 Objectives Understand the surgical treatment of breast cancer Be able to determine when a lumpectomy
More informationRadiation Treatment for Breast. Cancer. Melissa James Radiation Oncologist August 2015
Radiation Treatment for Breast Cancer Melissa James Radiation Oncologist August 2015 OUTLINE External Beam Radiation treatment. (What is Radiation, doctor?) Role of radiation. (Why am I getting radiation,
More informationStereotactic radiotherapy
Stereotactic radiotherapy Influence of patient positioning and fixation on treatment planning - clinical results Frank Zimmermann Institut für Radioonkologie Universitätsspital Basel Petersgraben 4 CH
More informationTreatment Planning for Breast Cancer: Contouring Targets. Julia White MD Professor
Treatment Planning for Breast Cancer: Contouring Targets Julia White MD Professor Outline 1. RTOG Breast Cancer Atlas 2. Target development on Clinical Trials Whole Breast Irradiation 2-D Radiotherapy
More informationGUIDELINES FOR RADIOTHERAPY IN EARLY BREAST CANCER
GUIDELINES FOR RADIOTHERAPY IN EARLY BREAST CANCER Authors: Dr N Thorp/ Dr P Robson On behalf of the Breast CNG Written: Originally - December 2008 Reviewed: Updated - December 2011 Agreed: Breast TSG
More information9.5. CONVENTIONAL RADIOTHERAPY TECHNIQUE FOR TREATING THYROID CANCER
9.5. CONVENTIONAL RADIOTHERAPY TECHNIQUE FOR TREATING THYROID CANCER ROBERT J. AMDUR, MD, SIYONG KIM, PhD, JONATHAN GANG LI, PhD, CHIRAY LIU, PhD, WILLIAM M. MENDENHALL, MD, AND ERNEST L. MAZZAFERRI, MD,
More informationSpinal Cord Doses in Palliative Lung Radiotherapy Schedules
Journal of the Egyptian Nat. Cancer Inst., Vol. 8, No., June: -, 00 Spinal Cord Doses in Palliative Lung Radiotherapy Schedules HODA AL-BOOZ, FRCR FFRRCSI M.D.* and CAROL PARTON, Ph.D.** The Departments
More informationWhere are we with radiotherapy for biliary tract cancers?
Where are we with radiotherapy for biliary tract cancers? Professor Maria A. Hawkins Associate Professor in Clinical Oncology MRC Group Leader/Honorary Consultant Clinical Oncologist CRUK MRC Oxford Institute
More informationFlattening Filter Free beam
Dose rate effect in external radiotherapy: biology and clinic Marta Scorsetti, M.D. Radiotherapy and Radiosurgery Dep., Istituto Clinico Humanitas, Milan, Italy Brescia October 8th/9th, 2015 Flattening
More informationBLADDER RADIOTHERAPY PLANNING DOCUMENT
A 2X2 FACTORIAL RANDOMISED PHASE III STUDY COMPARING STANDARD VERSUS REDUCED VOLUME RADIOTHERAPY WITH AND WITHOUT SYNCHRONOUS CHEMOTHERAPY IN MUSCLE INVASIVE BLADDER CANCER (ISRCTN 68324339) BLADDER RADIOTHERAPY
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews Prophylactic cranial irradiation in patients with non-small-cell lung cancer: a systematic review and meta-analysis of randomized controlled
More informationCancer of Unknown Primary Service
Cancer of Unknown Primary Service Dr Maurice Fernando Consultant In Specialist Palliative Care and CUP lead Doncaster and Bassetlaw Hospitals NHS FT Wakefield meeting -14-07-2016 CUP service CUP MDT
More information8/3/2017. Spine SBRT: A Clinician's Update On Techniques and Outcomes. Disclosures. Outline
Spine SBRT: A Clinician's Update On Techniques and Outcomes Chia-Lin (Eric) Tseng, MD FRCPC Radiation Oncologist Sunnybrook Health Sciences Centre University of Toronto August 3, 2017 Disclosures I have
More informationTecniche Radioterapiche U. Ricardi
Tecniche Radioterapiche U. Ricardi UNIVERSITA DEGLI STUDI DI TORINO Should we always rely on stage? T4N0M0 Stage IIIB T2N3M0 Early stage NSCLC The treatment of choice for early-stage NSCLC is anatomic
More informationLung Cancer Non-small Cell Local, Regional, Small Cell, Other Thoracic Cancers: The Question Isn t Can We, but Should We
Lung Cancer Non-small Cell Local, Regional, Small Cell, Other Thoracic Cancers: The Question Isn t Can We, but Should We Edward Garon, MD, MS Associate Professor Director- Thoracic Oncology Program David
More informationNeodjuvant chemotherapy
Neodjuvant chemotherapy Dr Robert Huddart Senior Lecturer and Honorary Consultant in Clinical Oncology Royal Marsden Hospital and Institute of Cancer Research Why consider neo-adjuvant chemotherapy? Loco-regional
More informationThe Role of Thoracic Radiotherapy as an Adjunct to Standard Chemotherapy in Limited-Stage Small Cell Lung Cancer
Evidence-based Series # 7-13-3 EDUCATION AND INFORMATION 2013 The Role of Thoracic Radiotherapy as an Adjunct to Standard Chemotherapy in Limited-Stage Small Cell Lung Cancer Members of the Lung Cancer
More informationProphylactic Cranial Irradiation in Acute Lymphoblastic Leukemia: Is there still an indication? Celine Bicquart, MD Radiation Medicine May 5, 2010
Prophylactic Cranial Irradiation in Acute Lymphoblastic Leukemia: Is there still an indication? Celine Bicquart, MD Radiation Medicine May 5, 2010 Outline Epidemiology Risk-groups Background & Rationale
More informationPEDIATRIC ORBITAL TUMORS RADIOTHERAPY PLANNING
PEDIATRIC ORBITAL TUMORS RADIOTHERAPY PLANNING ANATOMY ANATOMY CONT ANATOMY CONT. ANATOMY CONT. EYE OF A CHILD Normal tissue tolerance doses (in conventional #) TD 5/5 TD 50/5 Endpoint Gy Gy Optic nerve
More information肺癌放射治療新進展 Recent Advance in Radiation Oncology in Lung Cancer 許峰銘成佳憲國立台灣大學醫學院附設醫院腫瘤醫學部
肺癌放射治療新進展 Recent Advance in Radiation Oncology in Lung Cancer 許峰銘成佳憲國立台灣大學醫學院附設醫院腫瘤醫學部 Outline Current status of radiation oncology in lung cancer Focused on stage III non-small cell lung cancer Radiation
More informationTreatment of LS (Stage I-III) SCLC
Treatment of LS (Stage I-III) SCLC Prof C Faivre-Finn Manchester Lung Cancer Group Manchester Radiation Related Research Group ESMO-The Christie Preceptorship programme on Lung Cancer 9 th March 2018 @finn_corinne
More informationRadiotherapy in NSCLC: What are the ESMO Guidelines?
- The role of radiation in early stage - RT/CT for unresectable NSCLC - Brain metastasis - Oligometastatic disease Radiotherapy in NSCLC: What are the ESMO Guidelines? Jean-Yves DOUILLARD MD PhD Chief
More informationUpdate on Neoadjuvant Chemotherapy (NACT) in Cervical Cancer
Update on Neoadjuvant Chemotherapy (NACT) in Cervical Cancer Nicoletta Colombo, MD University of Milan-Bicocca European Institute of Oncology Milan, Italy NACT in Cervical Cancer NACT Stage -IB2 -IIA>4cm
More informationPlace of tumor bed radiosurgery and focal radiotherapy following resec7on of brain metastases: A new paradigm Lucyna Kepka
Place of tumor bed radiosurgery and focal radiotherapy following resec7on of brain metastases: A new paradigm Lucyna Kepka Department of Radia7on Oncology; M. Sklodowska- Curie Memorial Cancer Center and
More informationSBRT in early stage NSCLC
SBRT in early stage NSCLC Optimal technique and tumor dose Frank Zimmermann Clinic of Radiotherapy and Radiation Oncology University Hospital Basel Petersgraben 4 CH 4031 Basel radioonkologiebasel.ch Techniques
More informationLocally advanced head and neck cancer
Locally advanced head and neck cancer Radiation Oncology Perspective Petek Erpolat, MD Gazi University, Turkey Definition and Management of LAHNC Stage III or IV cancers generally include larger primary
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES CENTRAL NERVOUS SYSTEM EPENDYMOMA Last Revision Date July 2015 1 CNS Site Group Ependymoma Author: Dr. Norm Laperriere 1. INTRODUCTION 3 2.
More informationReference No: Author(s) 12/05/16. Approval date: committee. June Operational Date: Review:
Reference No: Title: Author(s) Systemic Anti-Cancer Therapy (SACT) Guidelines for Pancreatic Adenocarcinoma Dr Colin Purcell, Consultant Medical Oncologist & on behalf of the GI Oncologists Group, Cancer
More informationHot topics in Radiation Oncology for the Primary Care Providers
Hot topics in Radiation Oncology for the Primary Care Providers Steven Feigenberg, MD Professor Chief, Thoracic Oncology Vice Chair of Clinical Research April 19, 2018 Disclosures NONE 2 Early Stage Disease
More informationAllan Price NHS Lothian, Edinburgh, UK
Allan Price NHS Lothian, Edinburgh, UK Radiotherapy Dose Volume Timing Technique PCI Surgery Systemic agents 1 Study Dose Time Induction CT Ann Arbor 65.1-75.6 Gy Duke 73.6-80 Gy RTOG 77.4 Gy 74 Gy 6.5-7.5
More information